SCHEMBL4903947

SCHEMBL4903947

COC(=O)c1cc(S(=O)(=O)NCCc2ccc(Oc3ccccc3)cc2)cc(C)c1C

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
GAA P10253 1/20 0.51
KMT2A Q03164 1/20 0.51
AKR1C3 P42330 4/20 0.50
ALDH1A1 P00352 4/20 0.50
POLB P06746 1/20 0.50
TBXA2R P21731 1/20 0.49
TBXAS1 P24557 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.47
SGMS1 Q86VZ5 2/20 0.46
HTT P42858 1/20 0.45
ADAMTS4 O75173 1/20 0.45
MMP2 P08253 1/20 0.45
MMP13 P45452 1/20 0.45
MMP14 P50281 1/20 0.45
ADAMTS5 Q9UNA0 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903984 0.92 AKR1C3 (0.53) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4906445 0.91 PKM (0.47) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4898037 0.91 ALDH1A1 (0.56) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4904277 0.91 MAPT (0.50) MEN1KMT2AAKR1C3ALDH1A1TBXA2R
SCHEMBL4906174 0.90 HTT (0.52) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4904169 0.90 ALDH1A1 (0.46) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4900699 0.90 TBXAS1 (0.53) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4903809 0.89 ALDH1A1 (0.55) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4906408 0.88 ALDH1A1 (0.44) MEN1GAAKMT2AAKR1C3ALDH1A1
SCHEMBL4908345 0.88 MAPT (0.46) MEN1GAAKMT2AAKR1C3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MEN1 4859/4885GAA 1383/4885KMT2A 3602/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MEN1 4855/4885GAA 1367/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.